OTC · HRGN

Harvard Apparatus Regenerative Technology, Inc.

Closing price No closing price on file for HRGN from our free price source.
Last insider buy · Sep 15, 2026 Paid by CEO, Director Junli He in an open-market buy (Form 4). $2.15

Latest quarter · ended Sep 30, 2026

Cash got weaker, but sales grew

descriptionFiled Nov 13, 2026
Revenue growthSlower
+17.9%
Quarter ended Dec 31, 2024: +309.5% sales vs. a year beforeQuarter ended Mar 31, 2025: −21.1% sales vs. a year beforeQuarter ended Jun 30, 2025: +466.1% sales vs. a year beforeQuarter ended Sep 30, 2025: +108.5% sales vs. a year beforeQuarter ended Dec 31, 2025: −15.1% sales vs. a year beforeQuarter ended Mar 31, 2026: +402.2% sales vs. a year beforeQuarter ended Jun 30, 2026: +30.6% sales vs. a year beforeQuarter ended Sep 30, 2026: +17.9% sales vs. a year before
Dec '24Sep '26
$145K vs. $123K a year ago
Cash from operationsBetter
−$621K
Quarter ended Dec 31, 2024: −$1.12M cash from operationsQuarter ended Mar 31, 2025: −$758K cash from operationsQuarter ended Jun 30, 2025: −$941K cash from operationsQuarter ended Sep 30, 2025: −$1.47M cash from operationsQuarter ended Dec 31, 2025: −$664K cash from operationsQuarter ended Mar 31, 2026: −$937K cash from operationsQuarter ended Jun 30, 2026: −$569K cash from operationsQuarter ended Sep 30, 2026: −$621K cash from operations
Dec '24Sep '26
vs. −$1.47M a year ago
Share countDiluting
+17.0%
Quarter ended Dec 31, 2024: 15.92M sharesQuarter ended Mar 31, 2025: 15.92M sharesQuarter ended Jun 30, 2025: 17.17M sharesQuarter ended Sep 30, 2025: 17.17M sharesQuarter ended Dec 31, 2025: 17.58M sharesQuarter ended Mar 31, 2026: 17.58M sharesQuarter ended Jun 30, 2026: 17.58M sharesQuarter ended Sep 30, 2026: 20.09M shares
Dec '24Sep '26
20.09M shares vs. 17.17M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13
−1000+100 +100
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovCode C · Sep 11 · $718KOpen-market buy · Sep 11 · $380KOpen-market buy · Sep 15 · $14.5K
CEOCFOOther officersDirectorsJunJulAugSepOctNovCode C · Sep 11 · $718KOpen-market buy · Sep 11 · $380KOpen-market buy · Sep 15 · $14.5K

Last 6 months. A wider screen shows 12.

Showing 2 real trades. Bigger dot means a bigger trade.

Real trades, newest first

Sep 15 Junli He CEO, Director Open-market buy $14.5K 6,725 sh at $2.15
Sep 11 Junli He CEO, Director Open-market buy $380K 361,905 sh at $1.05

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in HRGN

No 13F holdings loaded for this stock.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist